SB
Shyamakant Binda Giri
About Shyamakant Binda Giri
Data last updated:
Shyamakant Binda Giri is a Ceo at Gland Pharma Ltd (since 2025). The companies operate in Healthcare and Pharma. Gland Pharma Ltd reported revenue of ₹6,747 Cr (FY 2026). Earlier, Shyamakant Binda Giri was a Managing Director at Amneal Healthcare Private Limited (2022–2025) and Director at Abbvie Biopharmaceuticals Private Limited (from 2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ceo | 16 Jan 2025 | 1978 | ₹6,747 Cr (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 01 Aug 2022 | 2021 | ₹55.76 Cr (FY 2025) | Active | |
| Director | 04 Aug 2014 | 2014 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shyamakant Binda Giri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Essaji Goolam Vahanvati | 00157299 | Gland Pharma Ltd | Director |
| Jia Ai Zhang | 09170927 | Gland Pharma Ltd | Director |
| Naina Lal Kidwai | 00017806 | Gland Pharma Ltd | Director |
| Ravi Shekhar Mitra | Gland Pharma Ltd | Cfo | |
| Sampath Kumar Pallerlamudi | Gland Pharma Ltd | Company Secretary | |
| Srinivas Sadu | 06900659 | Gland Pharma Ltd | Whole-Time Director |
| Udo Jahannes Vetter | 00707474 | Gland Pharma Ltd | Director |
| Wei Huang | 10818586 | Gland Pharma Ltd | Director |
| William Robert Keller | 11593622 | Gland Pharma Ltd | Director |
| Xingli Wang | 11899926 | Gland Pharma Ltd | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shyamakant Binda Giri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shyamakant Binda Giri
Shyamakant Binda Giri currently holds 1 directorship: Gland Pharma Ltd (Ceo, since 16 Jan 2025, revenue ₹6,747 Cr (FY 2026)).
Shyamakant Binda Giri was first appointed on 04 Aug 2014 as Director at Abbvie Biopharmaceuticals Private Limited. The most recent appointment on record is 16 Jan 2025 at Gland Pharma Ltd.
Shyamakant Binda Giri held 2 earlier board appointments: Amneal Healthcare Private Limited (Managing Director, 01 Aug 2022 to 09 Jan 2025); Abbvie Biopharmaceuticals Private Limited (Director, from 04 Aug 2014).
The current boards of Shyamakant Binda Giri's companies include Essaji Goolam Vahanvati (Gland Pharma Ltd), Jia Ai Zhang (Gland Pharma Ltd), Naina Lal Kidwai (Gland Pharma Ltd), Ravi Shekhar Mitra (Gland Pharma Ltd), Sampath Kumar Pallerlamudi (Gland Pharma Ltd), Srinivas Sadu (Gland Pharma Ltd), among others.